These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26384446)

  • 61. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses.
    Bürki F; Rossmanith W; Nowotny N; Pallan C; Möstl K; Lussy H
    Vet Q; 1990 Apr; 12(2):80-6. PubMed ID: 2163560
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of age and pregnancy on the antibody and cell-mediated immune responses of horses to equine herpesvirus 1.
    Gerber JD; Marron AE; Bass EP; Beckenhauer WH
    Can J Comp Med; 1977 Oct; 41(4):471-8. PubMed ID: 200320
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevention of Rhodococcus equi pneumonia of foals using two different inactivated vaccines.
    Varga J; Fodor L; Rusvai M; Soós I; Makrai L
    Vet Microbiol; 1997 Jun; 56(3-4):205-12. PubMed ID: 9226835
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Attempts to immunoprotect adult horses, specifically pregnant mares, with commercial vaccines against clinical disease induced by equine herpesvirus-1.
    Bürki F; Nowotny N; Oulehla J; Schmehlik O; Möstl K; Pallan C; Rossmanith E
    Zentralbl Veterinarmed B; 1991 Aug; 38(6):432-40. PubMed ID: 1659067
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models.
    Tsujimura K; Yamanaka T; Kondo T; Fukushi H; Matsumura T
    J Vet Med Sci; 2006 Oct; 68(10):1029-38. PubMed ID: 17085880
    [TBL] [Abstract][Full Text] [Related]  

  • 66. IgG antibody subclass response against equine herpesvirus type 4 in horses.
    Mizukoshi F; Maeda K; Hamano M; Iwata H; Matsumura T; Kondo T; Sugiura T
    Vet Immunol Immunopathol; 2002 Sep; 88(1-2):97-101. PubMed ID: 12088649
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of dexamethasone on antibody response of horses to vaccination with a combined equine influenza virus and equine herpesvirus-1 vaccine.
    Kreutzfeldt N; Chambers TM; Reedy S; Spann KM; Pusterla N
    J Vet Intern Med; 2024; 38(1):424-430. PubMed ID: 38141173
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets.
    Breathnach CC; Soboll G; Suresh M; Lunn DP
    Vet Immunol Immunopathol; 2005 Feb; 103(3-4):207-15. PubMed ID: 15621307
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Seroprevalence of equine herpesvirus 1 in mares and foals on a large Hunter Valley stud farm in years pre- and postvaccination.
    Foote CE; Gilkerson JR; Whalley JM; Love DN
    Aust Vet J; 2003 May; 81(5):283-8. PubMed ID: 15084039
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.
    Mumford JA; Bates J
    Vet Rec; 1984 Apr; 114(15):375-81. PubMed ID: 6328729
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ADCC and complement-dependent lysis as immune mechanisms against EHV-1 infection in the horse.
    Stokes A; Wardley RC
    Res Vet Sci; 1988 May; 44(3):295-302. PubMed ID: 2841731
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
    Platt R; Sponseller BA; Chiang YW; Roth JA
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Loop-mediated isothermal amplification assays for detection of Equid herpesvirus 1 and 4 and differentiating a gene-deleted candidate vaccine strain from wild-type Equid herpesvirus 1 strains.
    Nemoto M; Tsujimura K; Yamanaka T; Kondo T; Matsumura T
    J Vet Diagn Invest; 2010 Jan; 22(1):30-6. PubMed ID: 20093679
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Low-dose ginseng (Panax quinquefolium) modulates the course and magnitude of the antibody response to vaccination against equid herpesvirus I in horses.
    Pearson W; Omar S; Clarke AF
    Can J Vet Res; 2007 Jul; 71(3):213-7. PubMed ID: 17695597
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Control of EHV-1 viremia and nasal shedding by commercial vaccines.
    Goehring LS; Wagner B; Bigbie R; Hussey SB; Rao S; Morley PS; Lunn DP
    Vaccine; 2010 Jul; 28(32):5203-11. PubMed ID: 20538091
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes.
    Soboll G; Whalley JM; Koen MT; Allen GP; Fraser DG; Macklin MD; Swain WF; Lunn DP
    J Gen Virol; 2003 Oct; 84(Pt 10):2625-2634. PubMed ID: 13679596
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A review of equid herpesvirus 1 for the veterinary practitioner. Part A: clinical presentation, diagnosis and treatment.
    Dunowska M
    N Z Vet J; 2014 Jul; 62(4):171-8. PubMed ID: 24597778
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical signs and humoral immune response in horses following equine herpesvirus type-1 infection and their susceptibility to equine herpesvirus type-4 challenge.
    Stokes A; Corteyn AH; Murray PK
    Res Vet Sci; 1991 Sep; 51(2):141-8. PubMed ID: 1664967
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?
    Rosas CT; Goodman LB; von Einem J; Osterrieder N
    Expert Rev Vaccines; 2006 Feb; 5(1):119-31. PubMed ID: 16451114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.